Savara is a clinical-stage biopharmaceutical company building treatment options for uncommon respiratory ailments. Its lead solution applicant is definitely an immunostimulator called molgramostim. Molgramostim is in section three scientific trials to treat autoimmune pulmonary alveolar proteinosis, or aPAP.When you invest just 5 minutes with a pow